VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
-5.15%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$194M
AUM Growth
+$194M
(-16%)
Cap. Flow
+$79K
Cap. Flow
% of AUM
0.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
|
$23.5M |
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
$16.8M |
| 2 |
ELEV
Elevation Oncology
ELEV
|
$6.57M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$1.39B
| $79.4M | 40.88% | 4,289,304 | – | – |
|
|
ALMS
2
Alumis Inc. Common Stock
ALMS
$479M
| $30.2M | 15.53% | 2,826,048 | – | – |
|
|
3
Harmony Biosciences
HRMY
$2.12B
| $24.6M | 12.65% | 614,594 -420,802 | -41% | -$16.8M |
|
|
ARTV
4
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$76.7M
| $23.5M | 12.08% | +1,519,971 | New | +$23.5M |
|
|
SLRN
5
DELISTED
ACELYRIN
SLRN
| $19M | 9.77% | 3,852,470 | – | – |
|
6
ALX Oncology
ALXO
$62.7M
| $17.7M | 9.08% | 9,699,925 | – | – |
|
|
ELEV
7
DELISTED
Elevation Oncology
ELEV
| – | – | -2,434,255 | Closed | -$6.57M |
|